141 related articles for article (PubMed ID: 33468348)
1. [Sevoflurane sedation protocol in children with cerebral palsy undergoing botulinum toxin-A injections].
León-Valenzuela A; Román Malo C; González López M; Sánchez Palacios J; Sánchez Tarifa P; Del Pino Algarrada R
Rehabilitacion (Madr); 2021; 55(4):266-272. PubMed ID: 33468348
[TBL] [Abstract][Full Text] [Related]
2. [Sedation-analgesia protocol for the injection of botulinum toxin A in cerebral palsy].
Cantador-Hornero M; Jiménez-Espuch P; de Torres-Garcia I; Contreras-Jiménez M; Martínez-Mezo GL; Morales de Los Santos JM; Fernández-Jurado MI; Tirado-Reyes M
An Pediatr (Engl Ed); 2019 Nov; 91(5):317-327. PubMed ID: 30795881
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of a Propofol and Ketamine Based Procedural Sedation Protocol in Children with Cerebral Palsy Undergoing Botulinum Toxin A Injections.
Louer R; McKinney RC; Abu-Sultaneh S; Lutfi R; Abulebda K
PM R; 2019 Dec; 11(12):1320-1325. PubMed ID: 30761757
[TBL] [Abstract][Full Text] [Related]
4. Ketamine-based procedural sedation and analgesia for botulinum toxin A injections in children with cerebral palsy.
Chow C; Choong CT
Eur J Paediatr Neurol; 2016 Mar; 20(2):319-322. PubMed ID: 26640079
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
Dohin B; Garin C; Vanhems P; Kohler R
Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
[TBL] [Abstract][Full Text] [Related]
8. Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.
Blaszczyk I; Foumani NP; Ljungberg C; Wiberg M
Toxins (Basel); 2015 Nov; 7(11):4645-54. PubMed ID: 26561833
[TBL] [Abstract][Full Text] [Related]
9. 50% effective concentration of sevoflurane for immobility in cerebral palsy children undergoing botulinum toxin injection.
Kim K; Lee E; Jung SM; Baek J
Medicine (Baltimore); 2022 Oct; 101(42):e30928. PubMed ID: 36281165
[TBL] [Abstract][Full Text] [Related]
10. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
[TBL] [Abstract][Full Text] [Related]
11. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
12. Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.
Papavasiliou AS; Nikaina I; Foska K; Bouros P; Mitsou G; Filiopoulos C
Toxins (Basel); 2013 Mar; 5(3):524-36. PubMed ID: 23482250
[TBL] [Abstract][Full Text] [Related]
13. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
[TBL] [Abstract][Full Text] [Related]
14. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
Kim H; Kolaski K
NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
[TBL] [Abstract][Full Text] [Related]
15. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
[TBL] [Abstract][Full Text] [Related]
16. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects following botulinum toxin A injections in children with cerebral palsy.
Sapienza M; Kapoor R; Alberghina F; Maheshwari R; McCracken KL; Canavese F; Johari AN
J Pediatr Orthop B; 2023 Sep; 32(5):435-451. PubMed ID: 36723611
[TBL] [Abstract][Full Text] [Related]
18. Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy.
Edwards P; Sakzewski L; Copeland L; Gascoigne-Pees L; McLennan K; Thorley M; Kentish M; Ware R; Boyd RN
Pediatrics; 2015 Nov; 136(5):895-904. PubMed ID: 26482662
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
20. Validity of bispectral index monitoring during deep sedation in children with spastic cerebral palsy undergoing injection of botulinum toxin.
Jung SM; Lee E; Park SJ
Korean J Anesthesiol; 2019 Dec; 72(6):592-598. PubMed ID: 31378054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
